Literature DB >> 14770056

Estimation of antipsychotic effects on hospitalization risk in a naturalistic study with selection on unobservables.

David S Salkever1, Eric P Slade, Mustafa Karakus, Liisa Palmer, Patricia A Russo.   

Abstract

Estimates of effects of antipsychotic medication on hospitalization risk based on nonexperimental data may be affected by selection bias from either observable or unobservable factors. This study applies a statistical method, using instrumental variables, that controls for both types of possible selection bias. We use data from a large observational study of people under treatment for schizophrenia to estimate models of drug choice and hospitalization, including atypical (versus typical) medication effects on 12-month hospitalization risk. Results for younger patients (<age 45 years) indicate that unobservable factors bias the atypical effect estimate in a positive direction; correcting for this bias yields a significant negative effect on hospitalization risk. With data for older patients, our instrumental variables performed poorly and provided little information about possible selection bias. Obtaining detailed information on treatment history and other determinants of medication choice in future studies is critical for deriving more accurate estimates of medication effects from nonexperimental data.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14770056     DOI: 10.1097/01.nmd.0000110283.89270.23

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  9 in total

1.  Substance use, education, employment, and criminal activity outcomes of adolescents in outpatient chemical dependency programs.

Authors:  Ana I Balsa; Jenny F Homer; Michael T French; Constance M Weisner
Journal:  J Behav Health Serv Res       Date:  2007-12-07       Impact factor: 1.505

Review 2.  Use of instrumental variable in prescription drug research with observational data: a systematic review.

Authors:  Yong Chen; Becky A Briesacher
Journal:  J Clin Epidemiol       Date:  2010-12-16       Impact factor: 6.437

3.  Examining the relationship between clinical monitoring and suicide risk among patients with depression: matched case-control study and instrumental variable approaches.

Authors:  Hyungjin Myra Kim; Daniel Eisenberg; Dara Ganoczy; Katherine Hoggatt; Karen L Austin; Karen Downing; John F McCarthy; Mark Ilgen; Marcia Valenstein
Journal:  Health Serv Res       Date:  2010-10       Impact factor: 3.402

4.  Differential effects of atypical versus typical antipsychotic medication on earnings of schizophrenia patients : estimates from a prospective naturalistic study.

Authors:  David Salkever; Eric Slade; Mustafa Karakus
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

5.  An instrumental variables evaluation of the effect of antidepressant use on employment among HIV-infected women using antiretroviral therapy in the United States: 1996-2004.

Authors:  Omar Galárraga; David S Salkever; Judith A Cook; Stephen J Gange
Journal:  Health Econ       Date:  2010-02       Impact factor: 3.046

6.  Association Between Beta-Blockers and Mortality and Readmission in Older Patients with Heart Failure: an Instrumental Variable Analysis.

Authors:  Lauren Gilstrap; Andrea M Austin; A James O'Malley; Barbara Gladders; Amber E Barnato; Anna Tosteson; Jonathan Skinner
Journal:  J Gen Intern Med       Date:  2021-06-07       Impact factor: 6.473

7.  Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia.

Authors:  Haya Ascher-Svanum; Baojin Zhu; Douglas Faries; Ron Landbloom; Marvin Swartz; Jeff Swanson
Journal:  BMC Psychiatry       Date:  2006-02-21       Impact factor: 3.630

8.  The cost of relapse and the predictors of relapse in the treatment of schizophrenia.

Authors:  Haya Ascher-Svanum; Baojin Zhu; Douglas E Faries; David Salkever; Eric P Slade; Xiaomei Peng; Robert R Conley
Journal:  BMC Psychiatry       Date:  2010-01-07       Impact factor: 3.630

9.  Costs of treating patients with schizophrenia who have illness-related crisis events.

Authors:  Baojin Zhu; Haya Ascher-Svanum; Douglas E Faries; Xiaomei Peng; David Salkever; Eric P Slade
Journal:  BMC Psychiatry       Date:  2008-08-26       Impact factor: 3.630

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.